"Azithromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
| Descriptor ID |
D017963
|
| MeSH Number(s) |
D02.540.576.500.992.050
|
| Concept/Terms |
Zithromax- Zithromax
- Azitrocin
- Azadose
- Ultreon
- Zitromax
|
Below are MeSH descriptors whose meaning is more general than "Azithromycin".
Below are MeSH descriptors whose meaning is more specific than "Azithromycin".
This graph shows the total number of publications written about "Azithromycin" by people in this website by year, and whether "Azithromycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Azithromycin" by people in Profiles.
-
Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest. 2024 May; 165(5):1058-1069.
-
Association of Azithromycin Use With Cardiovascular Mortality. JAMA Netw Open. 2020 06 01; 3(6):e208199.
-
Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012. Sex Transm Dis. 2015 Jan; 42(1):6-12.
-
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol. 2008 Dec; 122(6):1138-1144.e4.
-
Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005 Apr 21; 352(16):1637-45.
-
Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med. 1996 Feb 15; 124(4):389-99.